Recruiting Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol NCT06764238 Conditions Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more Locations Anhui Medical University Second Affiliated Hospital — Hefei, Anhui, China Anhui Provincial Children's Hospital — Hefei, Anhui, China Fujian Medical University Union Hospital — Fuzhou, Fujian, China Guangzhou Women and Children's Medical Center — Guangzhou, Guangdong, China View all 27 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy) NCT05480449 Conditions B Cell Acute Lymphoblastic Leukemia (B-ALL), B Lineage Lymphoblastic Lymphoma, Burkitt Lymphoma, +16 more Locations Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States View Trial Details
Recruiting Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol NCT06882057 Conditions Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more Locations Anhui Medical University Second Affiliated Hospital — Hefei, Anhui, China Anhui Provincial Children's Hospital — Hefei, Anhui, China Chongqing Medical University Affiliated Children's Hospital — Chongqing, Chongqing Municipality, China Fujian Medical University Union Hospital — Fuzhou, Fujian, China View all 27 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL) NCT06785324 Conditions B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL, Burkitt Lymphoma, +17 more Locations University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois, United States View Trial Details
